Abstract:Among multiple pathways of intercellular communication operative in multicellular organisms, the trafficking of extracellular vesicles (EVs) and particles (EP) represents a unique mode of cellular information exchange with emerging roles in health and disease, including cancer. A distinctive feature of EV/EP-mediated cell-cell communication is that it involves simultaneous short- or long-range transfer of numerous molecular constituents (cargo) from donor to recipient cells. EV/EP uptake by donor cells elicits signalling or metabolic responses, or else leads to EV-re-emission or degradation. EVs are heterogeneous membranous structures released from cells via increasingly defined mechanisms involving either formation of multivesicular endosomes (exosomes) or budding from the plasma membrane (ectosomes). EPs (exomeres, supermeres) are membraneless complex particles, smaller than EVs and of less defined biogenesis and function. EVs/EPs carry complex assemblies of proteins, lipids and nucleic acids (RNA, DNA), which they shuttle into intercellular milieu, body fluids and recipient cells, via surface contact, fusion and different forms of internalization (endocytosis, micropinocytosis). While the physiological functions of EVs/EPs communication pathways continue to be investigated, their roles in cancer are increasingly well-defined. For example, EVs are involved in the transmission of cancer-specific molecular cargo, including mutant, oncogenic, transforming, or regulatory macromolecules to indolent, or normal cells, sometimes triggering their quasi-transformation-like states, or phenotypic alterations. Conversely, a reciprocal and avid uptake of stromal EVs by cancer cells may be responsible for modulating their oncogenic repertoire, as exemplified by the angiocrine effects of endothelial EVs influencing cancer cell stemness. EV exchanges during cancer progression have also been implicated in the formation of tumour stroma, angiogenesis and non-angiogenic neovascularization processes, immunosuppression, colonization of metastatic organ sites (premetastatic niche), paraneoplastic and systemic pathologies (thrombosis, diabetes, hepatotoxicity). Thus, an EV/EP-mediated horizontal transfer of cellular content emerges as a new dimension in cancer pathogenesis with functional, diagnostic, and therapeutic implications.

Dormancy and awakening of cancer cells: the extracellular vesicle-mediated cross-talk between Dr. Jekill and Mr. Hyde

Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution

Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces

The current paradigm and challenges ahead for the dormancy of disseminated tumor cells

Cell Dormancy and Tumor Refractory

Mechanisms of disseminated cancer cell dormancy: an awakening field

Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting

Unveiling the role of cellular dormancy in cancer progression and recurrence

Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Extracellular vesicle-based checkpoint regulation and immune state in cancer

Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications

Outlook and opportunities for engineered environments of breast cancer dormancy

The Relationship Between Mesenchymal Stem Cells and Tumor Dormancy

Extracellular vesicles and the regulation of tumor immunity: Current progress and future directions

Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis.

The dormant cancer cell life cycle

The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance

The Evolutionary Ecology of Dormancy in Nature and in Cancer

Intercellular Molecular Transfer Mediated by Extracellular Vesicles in Cancer